Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'
- PMID: 25066290
- DOI: 10.1111/bjd.13075
Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'
Comment on
-
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.N Engl J Med. 2013 Mar 7;368(10):924-35. doi: 10.1056/NEJMoa1215372. Epub 2013 Feb 24. N Engl J Med. 2013. PMID: 23432142 Clinical Trial.
-
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal.Br J Dermatol. 2014 Jul;171(1):10-3. doi: 10.1111/bjd.13073. Br J Dermatol. 2014. PMID: 25066288 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical